US Stock MarketDetailed Quotes

SLRX Salarius Pharmaceuticals

Watchlist
  • 1.5200
  • -0.1500-8.98%
Close Dec 30 16:00 ET
  • 1.6600
  • +0.1400+9.21%
Post 17:34 ET
2.19MMarket Cap-0.30P/E (TTM)

About Salarius Pharmaceuticals Company

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.

Company Profile

SymbolSLRX
Company NameSalarius Pharmaceuticals
Listing DateJan 29, 2015
Issue Price16.00
Founded2014
CEOMr. David J. Arthur
MarketNASDAQ
Employees2
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite X
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-832-834-6992
Websitehttp://salariuspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • David J. Arthur
  • Chief Executive Officer
  • 544.60K
  • Mark J. Rosenblum
  • Executive Vice President, Finance and Chief Financial Officer
  • 355.76K
  • Dr. William K. McVicar, PhD
  • Chairman of the Board
  • 82.26K
  • Dr. Paul Lammers, M. Sc.,M.D.
  • Lead Independent Director
  • 76.76K
  • Jonathan I. Lieber, M.B.A.
  • Independent Director
  • 53.76K
  • Arnold C. Hanish
  • Independent Director
  • 67.26K
  • Tess Burleson
  • Independent Director
  • 64.76K
  • Dr. Bruce J. McCreedy, PhD
  • Independent Director
  • 45.26K
Heat List
US
Overall
Symbol
Price
% Chg

No Data